Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000097:blood; D000241:Adenosine / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology*; D006152:Cyclic GMP; D004176:Dipyridamole / Q000494:pharmacology*; D006801:Humans; D009012:Mopidamol / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000097:blood; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011743:Pyrimidines / Q000494:pharmacology
D010726:Phosphodiesterase Inhibitors; D011743:Pyrimidines; D009012:Mopidamol; D004176:Dipyridamole; D010727:Phosphoric Diester Hydrolases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D006152:Cyclic GMP; D000241:Adenosine